Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Giraud-Gatineau

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|July 2, 2021
Evaluation of Strategies to Fight COVID-19: The French ParadigmAudrey Giraud-Gatineau, Philippe Gautret, Philippe Colson, et al.
Frontiers in Microbiology|September 9, 2020
Insights Into Subspecies Discrimination Potentiality From Bacteria MALDI-TOF Mass Spectra by Using Data Mining and Diversity StudiesAudrey Giraud-Gatineau, Gaetan Texier, Eric Garnotel, et al.
BMC Infectious Diseases|October 29, 2021
Using MALDI-TOF spectra in epidemiological surveillance for the detection of bacterial subgroups with a possible epidemic potentialAudrey Giraud-Gatineau, Gaetan Texier, Pierre-Edouard Fournier, et al.
Travel Medicine and Infectious Disease|December 14, 2020
Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycinMatthieu Million, Audrey Giraud-Gatineau, Jean-Christophe Lagier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 19, 2023
Corrigendum to "Does SARS-CoV-2 re-infection depend on virus variant?" [Clin Microbiol Infect 27 (9) (2021 Sep) 1374-1375]Philippe Gautret, Linda Houhamdi, Nhu Ngoc Nguyen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2021
Does SARS-CoV-2 re-infection depend on virus variant?Philippe Gautret, Linda Houhamdi, Nhu Ngog Nguyen, et al.
International Journal of Antimicrobial Agents|March 24, 2020
SARS-CoV-2: fear versus dataYanis Roussel, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, et al.
Journal of Clinical Medicine|August 7, 2021
Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, FranceLanceï Kaba, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 25, 2020
Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern FrancePhilippe Colson, Vera Esteves-Vieira, Audrey Giraud-Gatineau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 26, 2022
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measuresAudrey Giraud-Gatineau, Lancei Kaba, Céline Boschi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|July 2, 2021
Evaluation of Strategies to Fight COVID-19: The French ParadigmAudrey Giraud-Gatineau, Philippe Gautret, Philippe Colson, et al.
Frontiers in Microbiology|September 9, 2020
Insights Into Subspecies Discrimination Potentiality From Bacteria MALDI-TOF Mass Spectra by Using Data Mining and Diversity StudiesAudrey Giraud-Gatineau, Gaetan Texier, Eric Garnotel, et al.
BMC Infectious Diseases|October 29, 2021
Using MALDI-TOF spectra in epidemiological surveillance for the detection of bacterial subgroups with a possible epidemic potentialAudrey Giraud-Gatineau, Gaetan Texier, Pierre-Edouard Fournier, et al.
Travel Medicine and Infectious Disease|December 14, 2020
Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycinMatthieu Million, Audrey Giraud-Gatineau, Jean-Christophe Lagier, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 19, 2023
Corrigendum to "Does SARS-CoV-2 re-infection depend on virus variant?" [Clin Microbiol Infect 27 (9) (2021 Sep) 1374-1375]Philippe Gautret, Linda Houhamdi, Nhu Ngoc Nguyen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 1, 2021
Does SARS-CoV-2 re-infection depend on virus variant?Philippe Gautret, Linda Houhamdi, Nhu Ngog Nguyen, et al.
International Journal of Antimicrobial Agents|March 24, 2020
SARS-CoV-2: fear versus dataYanis Roussel, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, et al.
Journal of Clinical Medicine|August 7, 2021
Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, FranceLanceï Kaba, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 25, 2020
Temporal and age distributions of SARS-CoV-2 and other coronaviruses, southeastern FrancePhilippe Colson, Vera Esteves-Vieira, Audrey Giraud-Gatineau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 26, 2022
Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measuresAudrey Giraud-Gatineau, Lancei Kaba, Céline Boschi, et al.
Pageof 3